Showing results (3111-3120 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|February 1, 1991
Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomachG Somlo, J Doroshow, S Akman, et al.
Investigational New Drugs|February 1, 1991
A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, D Clarke-Pearson
Investigational New Drugs|February 1, 1991
Phase II trial of N-methylformamide in patients with metastatic melanomaO Eton, D F Bajorin, E S Casper, et al.
Investigational New Drugs|May 1, 1993
VRCTC-310--a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicityR A Newman, J C Vidal, L J Viskatis, et al.
Investigational New Drugs|May 1, 1993
Phase I trial of 5-fluorouracil by 24-hour infusion weeklyN B Haas, J B Hines, G R Hudes, et al.
Investigational New Drugs|May 1, 1993
Evaluation of amonafide in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, K J Kopecky, V Sondak, et al.
Investigational New Drugs|December 17, 2009
A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinomaChristopher W Ryan, Jacqueline Vuky, Joseph S Chan, et al.
Investigational New Drugs|December 17, 2009
Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cellsJana Vobořilová, Vlasta Němcová-Fürstová, Jitka Neubauerová, et al.
Investigational New Drugs|December 4, 2009
Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cellsHarish Kommera, Goran N Kaluđerović, Jutta Kalbitz, et al.
Investigational New Drugs|January 22, 2010
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemiaIsam Abdel-Karim, William K Plunkett, Susan O'Brien, et al.
Pageof 372